Tabuk Pharmaceutical Manufacturing Company

Tabuk Pharmaceutical Manufacturing Company develops, manufactures, markets, and distributes branded generic medicines for patients across Saudi Arabia and the wider Middle East and North Africa region. Established in 1994, the company has grown from a family business into a privately owned pharmaceutical enterprise with headquarters in Riyadh. Its operations combine product development with manufacturing in Saudi Arabia, while its portfolio is positioned around diversified and affordable generic medicines. The company also manufactures pharmaceutical products for international and regional partners through its plants in the Kingdom, extending its role beyond its own branded portfolio.

As a wholly owned subsidiary of Astra Industrial Group, Tabuk Pharmaceuticals works with public health institutions, private healthcare providers, and commercial partners across the region. Its business model includes licensing arrangements that permit partners to manufacture and market products in Saudi Arabia and neighboring markets. Recent agreements include marketing authorization, registration, importation, and promotion responsibilities for GLP-1 therapies addressing diabetes and chronic weight management in selected Middle Eastern countries. The company identifies localized specialty pharmaceutical production and differentiated technologies as central to strengthening domestic manufacturing capability, in line with Saudi Arabia's Vision 2030 healthcare and industrial objectives.